Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Cash: 2018-2024

Historic Change in Cash for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$988.9 million.

  • Legend Biotech's Change in Cash fell 154.43% to -$170.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $131.1 million, marking a year-over-year decrease of 64.45%. This contributed to the annual value of -$988.9 million for FY2024, which is 301.40% down from last year.
  • Legend Biotech's Change in Cash amounted to -$988.9 million in FY2024, which was down 301.40% from $491.0 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Change in Cash registered a high of $491.0 million during FY2023, and its lowest value of -$988.9 million during FY2024.
  • For the 3-year period, Legend Biotech's Change in Cash averaged around -$132.8 million, with its median value being $99.6 million (2022).
  • Per our database at Business Quant, Legend Biotech's Change in Cash soared by 392.96% in 2023 and then plummeted by 301.40% in 2024.
  • Over the past 5 years, Legend Biotech's Change in Cash (Yearly) stood at $371.7 million in 2020, then slumped by 37.26% to $233.2 million in 2021, then slumped by 57.29% to $99.6 million in 2022, then skyrocketed by 392.96% to $491.0 million in 2023, then plummeted by 301.40% to -$988.9 million in 2024.